JP2005519590A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005519590A5 JP2005519590A5 JP2003556018A JP2003556018A JP2005519590A5 JP 2005519590 A5 JP2005519590 A5 JP 2005519590A5 JP 2003556018 A JP2003556018 A JP 2003556018A JP 2003556018 A JP2003556018 A JP 2003556018A JP 2005519590 A5 JP2005519590 A5 JP 2005519590A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- polypeptide
- seq
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2001/027099 WO2002024888A2 (en) | 2000-09-01 | 2001-08-29 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US10/136,574 US7419799B2 (en) | 2001-08-29 | 2002-04-29 | Compositions and methods for the treatment of immune related diseases |
| PCT/US2002/024252 WO2003055440A2 (en) | 2001-08-29 | 2002-07-30 | Compositions and methods for the treatement of immune related diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005519590A JP2005519590A (ja) | 2005-07-07 |
| JP2005519590A5 true JP2005519590A5 (https=) | 2006-01-05 |
Family
ID=40481851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003556018A Pending JP2005519590A (ja) | 2001-08-29 | 2002-07-30 | 免疫関連疾患の治療のための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7419799B2 (https=) |
| EP (1) | EP1472273A4 (https=) |
| JP (1) | JP2005519590A (https=) |
| KR (1) | KR20040031031A (https=) |
| AU (2) | AU2002365246A1 (https=) |
| CA (1) | CA2458751A1 (https=) |
| MX (1) | MXPA04001986A (https=) |
| NZ (1) | NZ531311A (https=) |
| WO (1) | WO2003055440A2 (https=) |
| ZA (1) | ZA200401536B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001055336A2 (en) * | 2000-01-25 | 2001-08-02 | Hyseq, Inc. | Methods and materials relating to cd84-like polypeptides and polynucleotides |
| IL157624A0 (en) * | 2001-03-22 | 2004-03-28 | Bristol Myers Squibb Co | Polynucleotide encoding apex4 polypeptides and diagnostic and therapeutic compositions containing apex4 polypeptides |
| TW200823237A (en) | 2006-08-28 | 2008-06-01 | Nuvelo Inc | Antibodies to NTB-A |
| KR100975116B1 (ko) * | 2007-12-07 | 2010-08-11 | 이영조 | 가정용 음식물 쓰레기 처리장치의 미생물 공급장치 |
| CN105188749B (zh) | 2012-12-21 | 2017-12-19 | 西雅图基因公司 | 抗ntb‑a抗体及相关组合物和方法 |
| WO2014171721A1 (ko) * | 2013-04-16 | 2014-10-23 | 가톨릭대학교 산학협력단 | 아이케이 인자 및 아이케이 인자를 코딩하는 핵산의 약학적 용도 |
| KR101625112B1 (ko) | 2013-04-16 | 2016-05-27 | 가톨릭대학교 산학협력단 | 아이케이 인자 및 아이케이 인자를 코딩하는 핵산의 약학적 용도 |
| WO2015104711A1 (en) * | 2014-01-09 | 2015-07-16 | Hadasit Medical Research Services And Development Ltd. | Improved cell compositions and methods for cancer therapy |
| JP7458318B2 (ja) * | 2018-02-12 | 2024-03-29 | ハダシット メディカル リサーチ サービシーズ アンド ディベロップメント リミテッド | 癌治療のためのｓｌａｍｆ６スプライスバリアントの調節 |
| IL267614A (en) | 2019-06-24 | 2019-09-26 | Lotem Michal | Nucleic acids to modulate SLAMF6 isoforms |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5194596A (en) * | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
| US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
| WO2001055336A2 (en) | 2000-01-25 | 2001-08-02 | Hyseq, Inc. | Methods and materials relating to cd84-like polypeptides and polynucleotides |
| US7029677B2 (en) * | 2000-01-25 | 2006-04-18 | Nuvelo, Inc. | Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| US20040034194A1 (en) * | 2001-04-11 | 2004-02-19 | Pankaj Agarwal | Novel compounds |
| EP1223218A1 (en) * | 2000-11-03 | 2002-07-17 | Millennium Pharmaceuticals, Inc. | CD2000 and CD2001 molecules and uses thereof |
| JP2004533222A (ja) * | 2001-03-12 | 2004-11-04 | インサイト・ゲノミックス・インコーポレイテッド | 免疫グロブリンスーパーファミリータンパク質 |
| IL157624A0 (en) * | 2001-03-22 | 2004-03-28 | Bristol Myers Squibb Co | Polynucleotide encoding apex4 polypeptides and diagnostic and therapeutic compositions containing apex4 polypeptides |
| US7138243B2 (en) * | 2001-07-19 | 2006-11-21 | Innate Pharma, S.A. | NTB-A, a surface molecule involved in natural killer cells activity |
-
2001
- 2001-08-29 MX MXPA04001986A patent/MXPA04001986A/es unknown
-
2002
- 2002-04-29 US US10/136,574 patent/US7419799B2/en not_active Expired - Lifetime
- 2002-07-30 JP JP2003556018A patent/JP2005519590A/ja active Pending
- 2002-07-30 KR KR10-2004-7003104A patent/KR20040031031A/ko not_active Ceased
- 2002-07-30 AU AU2002365246A patent/AU2002365246A1/en not_active Abandoned
- 2002-07-30 CA CA002458751A patent/CA2458751A1/en not_active Abandoned
- 2002-07-30 WO PCT/US2002/024252 patent/WO2003055440A2/en not_active Ceased
- 2002-07-30 NZ NZ531311A patent/NZ531311A/en not_active IP Right Cessation
- 2002-07-30 EP EP02805924A patent/EP1472273A4/en not_active Withdrawn
-
2004
- 2004-02-25 ZA ZA2004/01536A patent/ZA200401536B/en unknown
-
2008
- 2008-07-29 US US12/182,090 patent/US20090017014A1/en not_active Abandoned
-
2009
- 2009-02-17 AU AU2009200614A patent/AU2009200614A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005535290A5 (https=) | ||
| JP2006516094A5 (https=) | ||
| JP2010162017A5 (https=) | ||
| RU2693084C2 (ru) | Антитела, направленные против интерлейкина-33 (il-33) | |
| JP5576072B2 (ja) | チロトロフィン（ｔｓｈ）受容体の抗原決定領域、その使用およびその抗体 | |
| Watanabe et al. | Leptin enhances cytokine/chemokine production by normal lung fibroblasts by binding to leptin receptor | |
| JP2010187677A5 (https=) | ||
| JP2007515942A5 (https=) | ||
| DK2383296T3 (en) | Antibody of the thyrotropin receptor and its applications | |
| Liang et al. | Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice | |
| JP2005519590A5 (https=) | ||
| JP2006510619A (ja) | 抗炎症剤としてのｈｍｇｂ断片の使用 | |
| JP2010511056A5 (https=) | ||
| CN104159919A (zh) | 使用抗干扰素γ抗体的治疗方法 | |
| MXPA05012497A (es) | Composiciones y metodos para el tratamiento del sindrome respiratorio agudo severo (sars). | |
| JP2021525236A (ja) | 抗ｉｌ１２／ｉｌ２３抗体でループスを治療する安全かつ有効な方法 | |
| US20170198044A1 (en) | Compositions and methods for safe and effective immunotherapy | |
| JP2005505274A5 (https=) | ||
| JP2006521082A5 (https=) | ||
| Giat et al. | The preferential use of anakinra in various settings of FMF: a review applied to an updated treatment-related perspective of the disease | |
| TW416960B (en) | Reshaped human antibody to human interleukin-8 | |
| JP2002507723A (ja) | リウマチ様関節炎の診断のための方法および組成物 | |
| EP2838559B1 (en) | Combination therapy of anti-mif antibodies and glucocorticoids | |
| WO2024168965A1 (zh) | 人IL-1R1和人IL-1RAcP多肽片段组合的同源二聚体蛋白质与用途 | |
| JP2005528080A5 (https=) |